Patent applications and USPTO patent grants for Xiao; Dong.The latest application filed is for "direct extended reach system and method".
Patent | Date |
---|---|
Substituted [1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitors Grant 11,352,320 - He , et al. June 7, 2 | 2022-06-07 |
Direct Extended Reach System And Method App 20220172209 - Vanhouten; Matthew G. ;   et al. | 2022-06-02 |
E-juice dripping type atomizer in electronic cigarette having u-shaped airflow channel Grant 11,285,278 - Li , et al. March 29, 2 | 2022-03-29 |
Electronic heating smoking paraphernalia capable of being rotated to extract cigarette and method for extracting cigarette by rotating smoking paraphernalia Grant 11,184,957 - Li , et al. November 23, 2 | 2021-11-23 |
Novel Substituted [1.1.1] Bicyclo Compounds As Indoleamine 2,3-dioxygenase Inhibitors App 20210198190 - He; Shuwen ;   et al. | 2021-07-01 |
Antidiabetic bicyclic compounds Grant 10,968,193 - Chen , et al. April 6, 2 | 2021-04-06 |
Antidiabetic spirochroman compounds Grant 10,968,232 - Miller , et al. April 6, 2 | 2021-04-06 |
Imidazo[1,2-c]quinazolin-5-amine Compounds With A2a Antagonist Properties App 20210053973 - ALI; Amjad ;   et al. | 2021-02-25 |
Compounds For Reducing The Viscosity Of Biological Formulations App 20200206350 - Chu; Lin ;   et al. | 2020-07-02 |
Aminopyrazine compounds with A2A antagonist properties Grant 10,688,082 - Zheng , et al. | 2020-06-23 |
Slow Cooker Capable Of Frying Food App 20200146497 - SHI; Junda ;   et al. | 2020-05-14 |
Electronic Heating Smoking Paraphernalia Capable Of Being Rotated To Extract Cigarette And Method For Extracting Cigarette By Ro App 20200093183 - ZHENG; Xudong ;   et al. | 2020-03-26 |
E-juice Dripping Type Atomizer App 20190336708 - ZHENG; Xudong ;   et al. | 2019-11-07 |
Antidiabetic Spirochroman Compounds App 20190337961 - Miller; Michael ;   et al. | 2019-11-07 |
Modular Multifunctional Electronic Smoking Paraphernalia App 20190328043 - LEI; Ping ;   et al. | 2019-10-31 |
Aminoquinazoline compounds as A.sub.2A antagonist Grant 10,138,212 - Ali , et al. Nov | 2018-11-27 |
Antidiabetic compounds Grant 10,059,667 - Chobanian , et al. August 28, 2 | 2018-08-28 |
Nk 1 Antagonists App 20180215729 - PALANI; Anandan ;   et al. | 2018-08-02 |
Aminopyrazine Compounds With A2a Antagonist Properties App 20180193314 - Zheng; Junying ;   et al. | 2018-07-12 |
Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist properties Grant 10,011,615 - Ali , et al. July 3, 2 | 2018-07-03 |
NK.sub.1 antagonists Grant 9,969,711 - Palani , et al. May 15, 2 | 2018-05-15 |
Antidiabetic bicyclic compounds Grant 9,957,219 - Bara , et al. May 1, 2 | 2018-05-01 |
Aminoquinazoline Compounds As A2a Antagonist App 20180037554 - Ali; Amjad ;   et al. | 2018-02-08 |
Antidiabetic bicyclic compounds Grant 9,840,512 - Brockunier , et al. December 12, 2 | 2017-12-12 |
Nk1 Antagonists App 20170283434 - Paliwal; Sunil ;   et al. | 2017-10-05 |
Antidiabetic Bicyclic Compounds App 20170217918 - Chen; Helen ;   et al. | 2017-08-03 |
Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine Compounds With A2a Antagonist Properties App 20170197991 - Ali; Amjad ;   et al. | 2017-07-13 |
NK.sub.1 antagonists Grant 9,688,693 - Paliwal , et al. June 27, 2 | 2017-06-27 |
Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A.sub.2A antagonist properties Grant 9,676,780 - Ali , et al. June 13, 2 | 2017-06-13 |
Nk 1 Antagonists App 20170029403 - Palani; Anandan ;   et al. | 2017-02-02 |
Heterocyclic compounds and methods of use thereof for the treatment of hepatitis C Grant 9,549,921 - He , et al. January 24, 2 | 2017-01-24 |
Antidiabetic Compounds App 20160332968 - Chobanian; Harry ;   et al. | 2016-11-17 |
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C Grant 9,493,461 - Dai , et al. November 15, 2 | 2016-11-15 |
NK.sub.1 antagonists Grant 9,469,629 - Palani , et al. October 18, 2 | 2016-10-18 |
Quinoxalines and AZA-quinoxalines as CRTH.sub.2 receptor modulators Grant 9,469,615 - Boyce , et al. October 18, 2 | 2016-10-18 |
Antidiabetic Bicyclic Compounds App 20160280626 - Bara; Thomas ;   et al. | 2016-09-29 |
Piperazine-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine Compounds With A2a Antagonist Properties App 20160194330 - Ali; Amjad ;   et al. | 2016-07-07 |
Application Management Method And Apparatus App 20160197789 - LAI; Zhoujian ;   et al. | 2016-07-07 |
Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases Grant 9,364,482 - Dai , et al. June 14, 2 | 2016-06-14 |
Heterocyclic Compounds And Methods Of Use Thereof For The Treatment Of Hepatitis C App 20160143895 - He; Shuwen ;   et al. | 2016-05-26 |
Substituted Benzofuran Compounds And Methods Of Use Thereof For The Treatment Of Viral Diseases App 20160136172 - Dai; Xing ;   et al. | 2016-05-19 |
Substituted Benzofuran Compounds And Methods Of Use Thereof For The Treatment Of Viral Diseases App 20160130259 - Liu; Hong ;   et al. | 2016-05-12 |
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases Grant 9,265,773 - McComas , et al. February 23, 2 | 2016-02-23 |
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C Grant 9,242,998 - He , et al. January 26, 2 | 2016-01-26 |
Antidiabetic Bicyclic Compounds App 20160002255 - Brockunier; Linda L. ;   et al. | 2016-01-07 |
Tetracyclic Heterocycle Compounds And Methods Of Use Thereof For The Treatment Of Hepatitis C App 20150368246 - Dai; Xing ;   et al. | 2015-12-24 |
Tetracyclic Heterocycle Compounds And Methods Of Use Thereof For The Treatment Of Hepatitis C App 20150368265 - He; Shuwen ;   et al. | 2015-12-24 |
Tetracyclic Heterocycle Compounds And Methods Of Use Thereof For The Treatment Of Hepatitis C App 20150361101 - Dai; Xing ;   et al. | 2015-12-17 |
Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine Compounds With A2a Antagonist Properties App 20150361098 - Ali; Amjad ;   et al. | 2015-12-17 |
Quinazolinone-type compounds as CRTH.sub.2 antagonists Grant 8,927,559 - Aslanian , et al. January 6, 2 | 2015-01-06 |
Nk1 Antagonists App 20140336158 - Paliwal; Sunil ;   et al. | 2014-11-13 |
Nk1 Antagonists App 20140296196 - Palani; Anandan ;   et al. | 2014-10-02 |
NK1 antagonists Grant 8,796,299 - Paliwal , et al. August 5, 2 | 2014-08-05 |
Tetracyclic Heterocycle Compounds And Methods Of Use Thereof For The Treatment Of Viral Diseases App 20140213571 - Liverton; Nigel J. ;   et al. | 2014-07-31 |
NK1 antagonists Grant 8,754,216 - Shah , et al. June 17, 2 | 2014-06-17 |
Ad Partner Revenue Share And Financial Terms Association Overrides App 20140058809 - Harvey; Sean ;   et al. | 2014-02-27 |
Fused tricyclic compounds for the treatment of inflammatory disorders Grant 8,598,158 - Xiao , et al. December 3, 2 | 2013-12-03 |
Quinoxalines And Aza-quinoxalines As Crth2 Receptor Modulators App 20130303517 - Boyce; Christopher W. ;   et al. | 2013-11-14 |
Quinazolinone-type Compounds As Crth2 Antagonists App 20130210805 - Aslanian; Robert G. ;   et al. | 2013-08-15 |
Nk1 Antagonists App 20130023503 - Paliwal; Sunil ;   et al. | 2013-01-24 |
Fused Tricyclic Compounds For The Treatment Of Inflammatory Disorders App 20120316154 - Xiao; Dong ;   et al. | 2012-12-13 |
NK1 Antagonists App 20120295879 - Palani; Anandan ;   et al. | 2012-11-22 |
NK.sub.1 antagonists Grant 8,273,895 - Paliwal , et al. September 25, 2 | 2012-09-25 |
Piperidine And Piperazine Derivatives And Methods Of Use Thereof App 20110245267 - Xiao; Dong ;   et al. | 2011-10-06 |
Pyridopyrimidine Derivatives And Methods Of Use Thereof App 20110245209 - Xiao; Dong ;   et al. | 2011-10-06 |
Bicyclic Pyranone Derivatives And Methods Of Use Thereof App 20110243940 - Xiao; Dong ;   et al. | 2011-10-06 |
NK.sub.1 antagonists Grant 8,026,364 - Shah , et al. September 27, 2 | 2011-09-27 |
Azine Derivatives and Methods of Use Thereof App 20110207734 - Palani; Anandan ;   et al. | 2011-08-25 |
Nitrogen-containing Heterocyclic Compounds And Methods Of Use Thereof App 20110152259 - Palani; Anandan ;   et al. | 2011-06-23 |
Nk1 Antagonists App 20110098468 - Paliwal; Sunil ;   et al. | 2011-04-28 |
NK.sub.1 antagonists Grant 7,902,366 - Paliwal , et al. March 8, 2 | 2011-03-08 |
Azetidinone derivatives and methods of use thereof Grant 7,884,080 - Aslanian , et al. February 8, 2 | 2011-02-08 |
Nitrogen-containing Heterocyclic Compounds And Methods Of Use Thereof App 20100227873 - Palani; Anandan ;   et al. | 2010-09-09 |
Nk 1 Antagonists App 20100190759 - PALANI; Anandan ;   et al. | 2010-07-29 |
Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia Grant 7,763,623 - Palani , et al. July 27, 2 | 2010-07-27 |
Nitrogen-containing heterocyclic compounds and methods of use thereof Grant 7,750,015 - Palani , et al. July 6, 2 | 2010-07-06 |
Nitrogen-containing heterocyclic compounds and methods of use thereof Grant 7,737,155 - Palani , et al. June 15, 2 | 2010-06-15 |
Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia Grant 7,723,342 - Palani , et al. May 25, 2 | 2010-05-25 |
NK1 antagonists Grant 7,709,641 - Shah , et al. May 4, 2 | 2010-05-04 |
Fused ring NK.sub.1 antagonists Grant 7,498,438 - Xiao , et al. March 3, 2 | 2009-03-03 |
Bridged ring NK.sub.1 antagonists Grant 7,354,922 - Xiao , et al. April 8, 2 | 2008-04-08 |
Azetidinone Derivatives and Methods of Use Thereof App 20080076751 - Aslanian; Robert G. ;   et al. | 2008-03-27 |
Azetidinone Derivatives and Methods of Use Thereof App 20080076750 - Aslanian; Robert G. ;   et al. | 2008-03-27 |
Nitrogen-containing Heterocyclic Compounds And Methods Of Use Thereof App 20080019978 - Palani; Anandan ;   et al. | 2008-01-24 |
Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia App 20070173495 - Palani; Anandan ;   et al. | 2007-07-26 |
Nitrogen-containing heterocyclic compounds and methods of use thereof App 20070066630 - Palani; Anandan ;   et al. | 2007-03-22 |
Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia App 20060264489 - Palani; Anandan ;   et al. | 2006-11-23 |
Bridged ring NK1 antagonists App 20060258665 - Xiao; Dong ;   et al. | 2006-11-16 |
NK1 antagonists Grant 7,122,677 - Reichard , et al. October 17, 2 | 2006-10-17 |
NK1 antagonists App 20060223804 - Shah; Sapna S. ;   et al. | 2006-10-05 |
NK1 antagonists App 20060199815 - Paliwal; Sunil ;   et al. | 2006-09-07 |
NK.sub.1 antagonists Grant 7,049,320 - Paliwal , et al. May 23, 2 | 2006-05-23 |
NK.sub.1 antagonists Grant 7,041,682 - Shih , et al. May 9, 2 | 2006-05-09 |
NK1 antagonists App 20060094720 - Shih; Neng-Yang ;   et al. | 2006-05-04 |
Fused ring NK1 antagonists App 20060040975 - Xiao; Dong ;   et al. | 2006-02-23 |
Pseudolaric acid-B derivatives, their preparation and pharmaceutical compositions Grant 6,887,895 - Yue , et al. May 3, 2 | 2005-05-03 |
NK1 antagonists Grant 6,878,732 - Wrobleski , et al. April 12, 2 | 2005-04-12 |
Novel pseudolaric acid-b derivatives, their preparation and pharmaceutical compositions App 20040235944 - Yue, Jianmin ;   et al. | 2004-11-25 |
NK1 antagonists App 20040072854 - Wrobleski, Michelle Laci ;   et al. | 2004-04-15 |
NK1 antagonists App 20040072867 - Shih, Neng-Yang ;   et al. | 2004-04-15 |
Selective neurokinin antagonists Grant 6,635,630 - Shih , et al. October 21, 2 | 2003-10-21 |
NK 1 antagonists App 20030158173 - Paliwal, Sunil ;   et al. | 2003-08-21 |
NK1 antagonists App 20030144270 - Reichard, Gregory A. ;   et al. | 2003-07-31 |
Selective neurokinin antagonists App 20030064980 - Shih, Neng-Yang ;   et al. | 2003-04-03 |
Selective Neurokinin Antagonists App 20020123491 - Shih, Neng-Yang ;   et al. | 2002-09-05 |
Selective neurokinin antagonists Grant 6,436,928 - Shih , et al. August 20, 2 | 2002-08-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.